Effects of male sexual maturity of reproductive endpoints relevant to DART studies in Wistar Hannover rats
Rattachement africain : jp, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Wistar Hannover rats have been utilized as one of major strains in regulatory toxicology studies. This study was performed to verify the appropriate age of male sexual maturity in the development and reproductive toxicity (DART) study in Wistar Hannover rats (RccHan:WIST) by comparing reproductive endpoints between 8, 10 and 12 weeks of ages. Although fertility showed a tendency toward decrease in 8-week-old males, copulation index was not different among three ages. Testis weights reached a plateau at 10 weeks of age, whereas weights of other reproductive organs developed until 12 weeks of age. Indices of spermatogenesis (sperm motility, number of sperm in the epididymis and testis and contents of morphologically abnormal sperm) showed age-related progress and did not fully develop except for 12-week-old. For histology, epididymal tubules in 8-week-old animals showed immaturity with tall epithelium. At cesarean section, dams mated with 8-week-old males showed high incidence of preimplantation loss and the number of live fetuses was less than 10. In conclusion, although reproductive performance attained maturity by age of 10 weeks, spermatogenesis was not fully established at 10-week-old, which could result in a low fertility index. Therefore, we recommend that Wistar Hannover male rats at 12-week-old or older are used to conduct DART study properly and evaluate any adverse effects on dams and embryo-fetal development.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effects of male sexual maturity of reproductive endpoints relevant to DART studies in Wistar Hannover rats
- Date Crossref
- 01/01/2014
- Éditeur
- Japanese Society of Toxicology
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Kissei Pharmaceutical (Japan) pays non établi dans la noticeEntreprise
-
Huntingdon College pays non établi dans la noticeUniversité ou école supérieure
-
Safety Research Laboratory pays non établi dans la noticeStructure de recherche
-
Ltd. Huntingdon Life Sciences Co. pays non établi dans la noticeEntreprise
Kissei Pharmaceutical (Japan), Huntingdon College et Safety Research Laboratory, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.